Swissmedic Updates Key Information on Drug Safety Reporting – What You Need to Know
Swissmedic has announced an update to its Drug Safety Reporting Duties in Switzerland information sheet. The adjustments include revised contact […]
Swissmedic has announced an update to its Drug Safety Reporting Duties in Switzerland information sheet. The adjustments include revised contact […]
Swissmedic has released an update to its guidance document regarding the Authorisation PSUR Signal Management TAM process, effective November 1,
Cardinal Health, Inc. (NYSE: CAH) has posted a slight gain in its latest trading session, reflecting modest investor optimism. With
Baxter Healthcare Limited has issued a Class 2 medicines recall after identifying a packaging error involving their Compound Sodium Lactate
The Medicines and Healthcare products Regulatory Agency (MHRA) has released its October 2025 safety update, detailing the latest insights and
Field Safety Notices (FSNs) issued between 20 and 24 October 2025 have recently been compiled for review by clinical, quality,
The U.S. Food and Drug Administration (FDA) has released an updated safety communication regarding the Hintermann Series H3 Total Ankle
Meta description: Artivion Inc. shares gain 0.55% on NYSE amid strong market positioning in the medical devices sector, reflecting steady
Swissmedic, the Swiss agency for therapeutic products, has announced the first authorisation of Filsuvez®, marking a pivotal event in the
Swissmedic, Switzerland’s surveillance authority for medicines and medical devices, has disclosed an exciting new opportunity in its Laboratory Department, particularly